Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Trials
Collaboration
Funding
Collaboration
Myriad Genetics, Memorial Sloan Kettering collaborate on MRD testing for breast cancer
Myriad Genetics is collaborating with Memorial Sloan Kettering Cancer Center to study the use of Myriad's minimal residual disease testing platform in predicting breast cancer treatment response.
September 18, 2023
Navigate BioPharma, Becton Dickinson collaborate on CDx solutions
Navigate BioPharma and Becton Dickinson have formed a strategic collaboration to use flow cytometry to develop and commercialize companion diagnostics (CDx) and clinical decision-making solutions.
September 11, 2023
TScan teams with Tempus to develop companion diagnostic for cancer cell therapy
The biotech firm TScan has identified Tempus as a company that can help it select the right treatments for patients. Tempus is the developer of xT CDx, a companion diagnostic that the FDA approved earlier this year.
July 11, 2023
Lunit, Japan national cancer center collaborate on AI-based pathology for oncology
In collaborative studies with the national cancer center, researchers are evaluating the potential of the Lunit Scope artificial intelligence biomarker platform to predict clinical outcomes for rectal cancer.
May 30, 2023
NIH-backed project develops scoring system for identifying long-COVID patients
While multiple earlier studies have assessed the effects of long COVID, previous efforts largely had retrospective designs, relied on electronic health record entries, and lacked an uninfected comparison group.
May 25, 2023
Thorne Healthtech, Arome Science partner to develop next-generation metabolomics test
Research studies using the test will leverage at-home blood collection conducted using its OneDraw medical device, Thorne HealthTech said.
May 15, 2023
Abbott joins consortium focused on viral outbreaks affected or caused by climate change
The CLIMADE consortium is focused on improving surveillance tools and expanding access to resources to decrease the impact of diseases and epidemics amplified by climate change.
April 20, 2023
National hepatitis C elimination program represents an historic opportunity, according to White House
The Biden-Harris administration proposes a five-year program to expand screening, testing, treatment, and prevention of hepatitis C, focusing on high-risk populations.
March 14, 2023
Sophia Genetics partnering with Agilent Technologies to offer cancer analysis solution
Through the partnership, the Sophia DDM Platform will be integrated with Agilent’s research-use-only SureSelect Cancer Comprehensive Genomic Profiling (CGP) Assay Kit.
March 14, 2023
Techcyte, Mayo Clinic to collaborate on algorithms for pathology platform
Techcyte’s Clinical Pathology AI Platform, which is CE-marked under IVDR and designated for research use only in the U.S., imports digital images of liquid-based samples from whole-slide scanners.
March 14, 2023
Illumina, Myriad Genetics provide U.S. access to HRD research test
The expanded partnership establishes a companion diagnostic (CDx) testing alliance for the pharmaceutical industry, which will enable more clinical research for gene-based, targeted therapies, the firms said.
March 6, 2023
Synergy Laboratories taps Sophia Genetics technology for cancer profiling
Synergy Oncology will pair its laboratory technologies with the Sophia DDM for Hereditary Cancers Solution for tumor profiling.
February 28, 2023
Page 1 of 5
Next Page
